Researchers will investigate the safety and effectiveness of a novel vaccine to protect horses against strangles, a serious infection caused by bacteria called Streptococcus equi.

Researchers will evaluate the potential of a combination adjunct therapy of hydrocortisone, vitamin C and thiamine in septic foals.

Researchers will investigate the impact of the bisphosphonate drug tiludronate (Tildren®) on equine bone.

Researchers will investigate the role of the male-specific Y chromosome, currently not part of the horse reference genome.

Researchers will investigate the effect of a widely used anti-inflammatory drug in horses on equine metabolic syndrome, a hormonal disorder associated with laminitis.

Researchers will gather baseline data on equine monocytes, a type of white blood cell important to fighting off infections and reducing inflammation.

Researchers will investigate diet-associated factors linked to the development of insulin dysregulation in horses.

Researchers will conduct a small clinical trial to investigate any benefits of extending antibiotic administration beyond 24 hours in horses undergoing surgery for colic.

Researchers will evaluate the use of platelet lysate, a natural blood-derived product, in its natural and gel form to help control infections in horses.

Researchers will determine appropriate dosing for the antifungal medication fluconazole, a treatment for coccidioidomycosis or Valley Fever, in alpacas.